{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:23:43Z","timestamp":1791696223789,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.tiv.2025.106016","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:04:10Z","timestamp":1738627450000},"page":"106016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Marked differences in thyroxine (T4) metabolism following in vitro exposure of Wistar rat and human hepatocytes to several reference CAR\/PXR nuclear receptor activators"],"prefix":"10.1016","volume":"104","author":[{"given":"Audrey","family":"Baze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Ory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliia","family":"Horbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Tinwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysiane","family":"Richert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2025.106016_bb0005","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/toxsci\/kfy149","article-title":"Role of YAP activation in nuclear receptor CAR-mediated proliferation of mouse hepatocytes","volume":"165","author":"Abe","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"Suppl. 3","key":"10.1016\/j.tiv.2025.106016_bb0010","doi-asserted-by":"crossref","first-page":"S428","DOI":"10.1093\/clinids\/5.Supplement_3.S428","article-title":"Pharmacokinetics and metabolism of rifampin in humans","volume":"5","author":"Acocella","year":"1983","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.tiv.2025.106016_bb0015","doi-asserted-by":"crossref","first-page":"12352","DOI":"10.3390\/ijms241512352","article-title":"Local thyroid hormone action in brain development","volume":"24","author":"Alcaide Martin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2025.106016_bb0020","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3109\/00498254.2012.676693","article-title":"Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers","volume":"42","author":"Alexandre","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tiv.2025.106016_bb0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yrtph.2018.07.025","article-title":"Human relevance of follicular thyroid tumors in rodents caused by non-genotoxic substances","volume":"98","author":"Bartsch","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106016_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2023.105763","article-title":"Comparison of in vitro thyroxine (T4) metabolism between Wistar rat and human hepatocyte cultures","volume":"96","author":"Baze","year":"2024","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2025.106016_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104884","article-title":"Metribuzin-induced non-adverse liver changes result in rodent-specific non-adverse thyroid effects via uridine 5\u2032-diphospho-glucuronosyltransferase (UDPGT, UGT) modulation","volume":"122","author":"Bomann","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106016_bb0040","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.3390\/jcm12227120","article-title":"Drug-drug interactions involving dexamethasone in clinical practice: myth or reality?","volume":"12","author":"Bourdin","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tiv.2025.106016_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166101","article-title":"The xenobiotic receptors PXR and CAR in liver physiology, an update","volume":"1867","author":"Cai","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.tiv.2025.106016_bb0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","article-title":"Hepatocyte-based in vitro model for assessment of drug-induced cholestasis","volume":"274","author":"Chatterjee","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106016_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-0711-5-3","article-title":"Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor","volume":"5","author":"Chen","year":"2006","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.tiv.2025.106016_bb0060","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fendo.2018.00474","article-title":"Metabolic effects of the intracellular regulation of thyroid hormone: old players, new concepts","volume":"9","author":"Cicatiello","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tiv.2025.106016_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2024.105911","article-title":"Investigating the mechanisms of action of thyroid disruptors: a multimodal approach that integrates in vitro and metabolomic analysis","volume":"100","author":"Clavel Rolland","year":"2024","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2025.106016_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/edrv-12-2-135","article-title":"The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland","volume":"12","author":"Curran","year":"1991","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tiv.2025.106016_bb0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12940-019-0509-z","article-title":"Thyroid hormone levels associate with exposure to polychlorinated biphenyls and polybrominated biphenyls in adults exposed as children","volume":"18","author":"Curtis","year":"2019","journal-title":"Environ. Health"},{"key":"10.1016\/j.tiv.2025.106016_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0041-008X(91)90030-I","article-title":"Comparison of the effects of propylthiouracil, amiodarone, diphenylhydantoin, phenobarbital, and 3-methylcholanthrene on hepatic and renal T4 metabolism and thyroid gland function in rats","volume":"111","author":"De Sandro","year":"1991","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106016_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/10408444.2013.835786","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"44","author":"Elcombe","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tiv.2025.106016_bb0090","author":"EMA"},{"key":"10.1016\/j.tiv.2025.106016_bb0095","doi-asserted-by":"crossref","DOI":"10.2903\/j.efsa.2018.5311","article-title":"Guidance for the identification of endocrine disruptors in the context of regulations (EU) no 528\/2012 and (EC) no 1107\/2009","volume":"16","author":"European Chemical Agency (ECHA) and European Food Safety Authority (EFSA) with the technical support of the Joint Research Centre (JRC)","year":"2018","journal-title":"EFSA J."},{"key":"10.1016\/j.tiv.2025.106016_bb0100","article-title":"Establishment of cumulative assessment groups of pesticides for their effects on the thyroid","volume":"17","author":"European Food Safety Authority (EFSA)","year":"2019","journal-title":"EFSA J."},{"key":"10.1016\/j.tiv.2025.106016_bb0105","author":"FDA"},{"key":"10.1016\/j.tiv.2025.106016_bb0110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00204-020-02961-6","article-title":"A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer","volume":"95","author":"Foster","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2025.106016_bb0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.crtox.2021.03.002","article-title":"Primary hepatocytes isolated from human and porcine donors display similar patterns of cytochrome p450 expression following exposure to prototypical activators of AhR, CAR and PXR","volume":"2","author":"Gerbal-Chaloin","year":"2021","journal-title":"Curr. Res. Toxicol."},{"key":"10.1016\/j.tiv.2025.106016_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tiv.2014.05.009","article-title":"Determination of liver specific toxicities in rat hepatocytes by high content imaging during 2-week multiple treatment","volume":"30","author":"Germano","year":"2015","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2025.106016_bb0125","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/004982597239994","article-title":"Rifampin and rifabutin and their metabolism by human liver esterases","volume":"27","author":"Jamis-Dow","year":"1997","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tiv.2025.106016_bb0130","series-title":"Poster Presented at the Eurotox Congress, Copenhagen","article-title":"Generation of acceptability criteria for the in vitro primary hepatocyte MoA assay via historical control database generation for confirmation of assay validity","author":"Kent","year":"2024"},{"key":"10.1016\/j.tiv.2025.106016_bb0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1124\/mol.119.116616","article-title":"Mechanistic insights of phenobarbital-mediated activation of human but not mouse Pregnane X receptor","volume":"96","author":"Li","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106016_bb0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.tiv.2025.106016_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103855","article-title":"Nuclear receptors in renal health and disease","volume":"76","author":"Luan","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tiv.2025.106016_bb0150","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/toxsci\/kfu038","article-title":"Phenobarbital induces cell cycle transcriptional responses in mouse liver humanized for constitutive androstane and pregnane x receptors","volume":"139","author":"Luisier","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2025.106016_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.959902","article-title":"The role of pregnane X receptor (PXR) in substance metabolism","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tiv.2025.106016_bb0160","doi-asserted-by":"crossref","first-page":"17277","DOI":"10.1074\/jbc.M300138200","article-title":"Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes","volume":"278","author":"Maglich","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2025.106016_bb0165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0027-5107(95)00139-5","article-title":"Mechanistic considerations for the relevance of animal data on thyroid neoplasia to human risk assessment","volume":"333","author":"McClain","year":"1995","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tiv.2025.106016_bb0170","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1067\/mcp.2000.110215","article-title":"In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone","volume":"68","author":"McCune","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2025.106016_bib341","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408444.2024.2422890","article-title":"A weight of evidence review on the mode of action, adversity, and the human relevance of xylene\u2019s observed thyroid effects in rats","author":"Morris-Schaffer","year":"2025","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.tiv.2025.106016_bb0175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tiv.2025.106016_bb0180","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1124\/dmd.119.088922","article-title":"Organic anion-transporting polypeptide genes are not induced by the Pregnane X receptor activator rifampin: studies in hepatocytes in vitro and in monkeys in vivo","volume":"47","author":"Niu","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106016_bb0185","doi-asserted-by":"crossref","DOI":"10.1289\/EHP5297","article-title":"Evaluating Chemicals for Thyroid Disruption: opportunities and challenges with in vitro testing and adverse outcome pathway approaches","volume":"127","author":"Noyes","year":"2019","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tiv.2025.106016_bb0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.vascn.2015.03.002","article-title":"Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture","volume":"73","author":"Oorts","year":"2015","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.tiv.2025.106016_bb0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.vascn.2017.10.007","article-title":"Extra collagen overlay prolongs the differentiated phenotype in sandwich-cultured rat hepatocytes","volume":"90","author":"Oorts","year":"2018","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.tiv.2025.106016_bb0200","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1124\/dmd.113.052415","article-title":"Transcriptomic hepatotoxicity signature of chlorpromazine after short- and long-term exposure in primary human sandwich cultures","volume":"41","author":"Parmentier","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106016_bb0205","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s00204-017-1930-0","article-title":"Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes","volume":"91","author":"Parmentier","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2025.106016_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115831","article-title":"Evaluation of human relevance of Nicofluprole-induced rat thyroid disruption","volume":"435","author":"Parmentier","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106016_bb0215","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cbi.2008.10.054","article-title":"Effects of Andrographis paniculata extract and Andrographolide on hepatic cytochrome P450 mRNA expression and monooxygenase activities after in vivo administration to rats and in vitro in rat and human hepatocyte cultures","volume":"179","author":"Pekthong","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2025.106016_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164642","article-title":"Transactivation assays to assess canine and rodent Pregnane X receptor (PXR) and constitutive Androstane receptor (CAR) activation","volume":"11","author":"Pinne","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tiv.2025.106016_bb0225","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.toxrep.2019.09.010","article-title":"Cross-species comparison of CAR-mediated procarcinogenic key events in a 3D liver microtissue model","volume":"6","author":"Plummer","year":"2019","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.tiv.2025.106016_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153411","article-title":"The effects of hexabromocyclododecane on the transcriptome and hepatic enzyme activity in three human HepaRG-based models","volume":"485","author":"Proen\u00e7a","year":"2023","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2025.106016_bb0235","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1210\/en.2004-1350","article-title":"Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism","volume":"146","author":"Qatanani","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.tiv.2025.106016_bb0240","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/00498254.2013.847990","article-title":"In vitro metabolism of thyroxine by rat and human hepatocytes","volume":"44","author":"Richardson","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tiv.2025.106016_bb0245","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bcp.2010.06.043","article-title":"Dexamethasone transcriptionally increases the expression of the pregnane X receptor and synergistically enhances pyrethroid esfenvalerate in the induction of cytochrome P450 3A23","volume":"80","author":"Shi","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106016_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061802","article-title":"Xenobiotic-induced hepatocyte proliferation associated with constitutive active\/androstane receptor (CAR) or peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) is enhanced by pregnane X receptor (PXR) activation in mice","volume":"8","author":"Shizu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tiv.2025.106016_bb0255","first-page":"79","article-title":"Metabolism of dexamethasone: sites and activity in mammalian tissues","volume":"16","author":"Siebe","year":"1993","journal-title":"Ren. Physiol. Biochem."},{"key":"10.1016\/j.tiv.2025.106016_bb0260","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tiv.2016.08.006","article-title":"Development of an in vitro high content imaging assay for quantitative assessment of CAR-dependent mouse, rat, and human primary hepatocyte proliferation","volume":"36","author":"Soldatow","year":"2016","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2025.106016_bb0265","first-page":"1467","article-title":"Coordinate regulation of xenobiotic and bile acid homeostasis by Pregnane X receptor","volume":"29","author":"Staudinger","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106016_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713246","article-title":"Increased cell proliferation as a key event in chemical carcinogenesis: application in an integrated approach for the testing and assessment of non-genotoxic carcinogenesis","volume":"24","author":"Strupp","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2025.106016_bb0275","doi-asserted-by":"crossref","first-page":"132S","DOI":"10.1042\/bst022132s","article-title":"Origins of hepatomegaly produced by dexamethasone (DEX), pregnenolone 16 alpha-carbonitrile (PCN) and phenobarbitone (PB) in female Sprague-Dawley rats","volume":"22","author":"Thatcher","year":"1994","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.tiv.2025.106016_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105154","article-title":"Isoflucypram: combining in vivo and NAMs data in a weight of evidence approach to demonstrate the human non-relevance of the mode of action leading to the subtle thyroid effects observed in the rat","volume":"131","author":"Tinwell","year":"2022","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106016_bb0285","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.yrtph.2014.09.011","article-title":"Liver tumor formation in female rat induced by fluopyram is mediated by CAR\/PXR nuclear receptor activation","volume":"70","author":"Tinwell","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106016_bb0290","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0006-2952(97)00166-4","article-title":"In vitro metabolism of dexamethasone (DEX) in human liver and kidney: the involvement of CYP3A4 and CYP17 (17,20 LYASE) and molecular modelling studies","volume":"54","author":"Tomlinson","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106016_bb0295","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0960-0760(97)00038-1","article-title":"Dexamethasone metabolism in vitro: species differences","volume":"62","author":"Tomlinson","year":"1997","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tiv.2025.106016_bb0300","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1124\/dmd.32.8.834","article-title":"Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes","volume":"32","author":"Turncliff","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106016_bb0305","author":"US EPA"},{"key":"10.1016\/j.tiv.2025.106016_bb0310","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1124\/dmd.121.000498","article-title":"Mechanisms by which inducers of drug metabolizing enzymes Alter thyroid hormones in rats","volume":"50","author":"Vansell","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106016_bb0315","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1515\/DMDI.1996.13.1.41","article-title":"Phenobarbital metabolism by hepatocytes isolated from rat","volume":"13","author":"V\u00e9rit\u00e9","year":"1996","journal-title":"Drug Metabol. Drug Interact."},{"key":"10.1016\/j.tiv.2025.106016_bb0320","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2165\/00003088-200342150-00003","article-title":"Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes","volume":"42","author":"Wang","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.tiv.2025.106016_bb0325","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jat.4427","article-title":"Boscalid shows increased thyroxin-glucuronidation in rat but not in human hepatocytes in vitro","volume":"43","author":"Wiemann","year":"2023","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tiv.2025.106016_bb0330","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/10408444.2021.1939654","article-title":"Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)","volume":"51","author":"Yamada","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tiv.2025.106016_bb0335","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/187231210791698410","article-title":"Induction of CYP2B6 and CYP3A4 by 1-Aminobenzotriazole (ABT) in human hepatocytes","volume":"4","author":"Yang","year":"2010","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.tiv.2025.106016_bb0340","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1124\/dmd.121.000481","article-title":"Distinct roles of the sister nuclear receptors PXR and CAR in liver Cancer development","volume":"50","author":"Yoshinari","year":"2022","journal-title":"Drug Metab. Dispos."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233325000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233325000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T21:41:36Z","timestamp":1740692496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233325000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":69,"alternative-id":["S0887233325000104"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2025.106016","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marked differences in thyroxine (T4) metabolism following in vitro exposure of Wistar rat and human hepatocytes to several reference CAR\/PXR nuclear receptor activators","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2025.106016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106016"}}